Inactive Instrument

Motif Bio plc Share Price Nasdaq

Equities

Duration

Period

Style

MOTF BIO : BiVictriX Debuts on London's AIM Segment After $10 Million IPO	11/08/21	MT
Motif Bio plc Announces Board Appointments	14/06/21	CI
BiVictriX Therapeutics Ltd. cancelled the acquisition of Motif Bio plc in a reverse merger transaction.	13/06/21	CI
Motif Bio plc Reports Earnings Results for the Full Year Ended December 31, 2020	10/05/21	CI
Motif Bio plc Announces Board Changes	10/05/21	CI
Orange Avenue Technologies LLC entered into a Stock Purchase Agreement to acquire Motif BioSciences, Inc. from Motif Bio plc	25/02/21	CI
Motif Bio : Signs Reverse Takeover of Antibody-Drug Conjugate Company	27/01/21	MT
BiVictriX Therapeutics Ltd. entered into a sale and purchase agreement to acquire Motif Bio plc for £5.5 million in a reverse merger transaction.	26/01/21	CI
Motif Bio plc Reports Earnings Results for the Half Year Ended June 30, 2020	12/10/20	CI
Motif Bio plc Reports Earnings Results for the Full Year Ended December 31, 2019	01/09/20	CI
Motif Bio plc Announces Delay in Publication of Final Results for the Year Ended 31 December 2019	22/06/20	CI
Motif Bio Appoints Adviser for Reverse Takeover Candidate	01/06/20	CI
Motif Seeks Reverse Takeover Candidate	05/05/20	CI
Motif Bio plc Announces Management Changes	04/05/20	CI
Motif Bio plc and Motif BioSciences Inc. Enter into Loan Amendment and Release Agreement with Hercules Capital In	29/01/20	CI

Motif Bio : 2020 Annual Report and Accounts	10/05/21	PU
Motif Bio : Results of AGM	30/09/20	PU
Motif Bio : Notification of Interim Results	23/09/20	PU
Motif Bio : Annual Report and Accounts & Notice of AGM	09/09/20	PU
Motif Bio : Delay in publication of Final Results	22/06/20	PU

14/02/19

Motif Bio plc is a United Kingdom-based shell company. The Company is not engaged in any operation.

Sector

	1st Jan change	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	+11.91%	118B
REGENERON PHARMACEUTICALS, INC.	+11.60%	106B
BIONTECH SE	-4.68%	24.28B
ARGENX SE	-0.82%	21.96B
GENMAB A/S	-10.12%	18.16B
WUXI APPTEC CO., LTD.	-42.12%	16.37B
BEIGENE, LTD.	-17.47%	15.56B
NEUROCRINE BIOSCIENCES, INC.	+2.77%	13.63B
SAREPTA THERAPEUTICS, INC.	+34.58%	12.27B